Sign in

CIK 0001400118

  • Emerging growth company

Sagimet Biosciences Inc.

Sign in to watch
Ticker
SGMT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205991472
Phone
+1 650-561-8600
Business address
950 TOWER LANE, STE 1500, FOSTER CITY, CA, 94404
Former names
3-V Biosciences, Inc.
  1. 4 Open-market buy President & CEO bought 12,100 shares at $5.27 ($63,731)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Other disposition 10% owner disposed of 1,110,950 shares (other)
  4. 4 Other disposition 10% owner disposed of 1,110,950 shares (other)
  5. 4 Other disposition 10% owner disposed of 1,110,950 shares (other)
  6. 4 Other disposition 10% owner disposed of 1,110,950 shares (other)
  7. 4 Other disposition 10% owner disposed of 850,000 shares (other)
  8. 4 Open-market buy President & CEO bought 1,600 shares at $4.10 ($6,560)
  9. 4 Grant or award General Counsel and CCO acquired 171,420 shares (grant or award)
  10. 4 Grant or award Chief Medical Officer acquired 89,570 shares (grant or award)
  11. 4 Grant or award Executive Chairman acquired 150,750 shares (grant or award)
  12. 4 Grant or award President & CEO acquired 624,910 shares (grant or award)
  13. 4 Open-market buy President & CEO bought 590 shares at $2.35 ($1,387)
  14. 4 Exercise or conversion Executive Chairman acquired 5,630 shares (option exercise)
  15. 4 Open-market buy 10% owner bought 30,000 shares at $16.00 ($480,000)
  16. 4 Conversion 10% owner acquired 1,860,712 shares (conversion)
  17. 4 Open-market buy Director bought 46,875 shares at $16.00 ($750,000)
  18. 4 Conversion Director acquired 1,654,701 shares (conversion)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 4 of 5 · 100 filings